Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| HOUR | PRESS-RELEASE | neutral | 4/10 | Hour Loop reported Q1 2026 revenue of $29.9M (+16% YoY) and net income of $0.82M (+26% YoY), with EPS of $0.02 per dilut | May 12, 2026 |
| CAPR | PRESS-RELEASE | neutral | 5/10 | Capricor Therapeutics reported Q1 2026 EPS of -$0.59, missing consensus of -$0.54 by ~9.3%, with no revenue. The key cat | May 12, 2026 |
| BOLT | PRESS-RELEASE | bearish | 7/10 | Bolt Biotherapeutics reported Q1 2026 EPS of -$4.31, missing consensus of -$3.60 by 19.7%, and collaboration revenue col | May 12, 2026 |
| ROLR | PRESS-RELEASE | mixed | 7/10 | High Roller Technologies reported Q1 2026 net revenues of $3.4M, down 35% YoY from $5.2M, driven by a deliberate exit fr | May 12, 2026 |
| LBRX | PRESS-RELEASE | neutral | 4/10 | LB Pharmaceuticals reported Q1 2026 EPS of -$0.67, in line with consensus of -$0.67, and a net loss of $19.1M vs $5.3M a | May 12, 2026 |
| BEEP | PRESS-RELEASE | bearish | 7/10 | Mobile Infrastructure reported Q1 2026 EPS of -$0.19, a 58.3% miss vs consensus of -$0.12, with total revenue of $7.9M d | May 12, 2026 |
| TELA | PRESS-RELEASE | bearish | 6/10 | TELA Bio reported Q1 2026 revenue of $19.1M (+3% YoY), slightly above the $19.0M consensus, and an EPS of -$0.21 (GAAP), | May 12, 2026 |
| REED | PRESS-RELEASE | bearish | 8/10 | Reeds, Inc. reported a disastrous Q1 2026 with net sales plunging 29% YoY to $7.1M (vs $10.0M), gross margin collapsing | May 12, 2026 |
| BRCB | PRESS-RELEASE | bullish | 6/10 | Black Rock Coffee Bar reported Q1 2026 EPS of $0.04, beating the $0.02 consensus by 100%, and revenue of $55.5M, slightl | May 12, 2026 |
| NYXH | PRESS-RELEASE | mixed | 6/10 | Nyxoah reported Q1 2026 revenue of €6.4M, up from €1.1M YoY, driven by U.S. Genio launch, but EPS of -€0.59 missed conse | May 12, 2026 |
| LMRI | PRESS-RELEASE | bearish | 7/10 | Lumexa Imaging reported Q1 2026 GAAP EPS of $0.02, a massive miss vs the $0.12 consensus, and revenue of $252.5M slightl | May 12, 2026 |
| STXS | PRESS-RELEASE | mixed | 6/10 | Stereotaxis reported Q1 2026 revenue of $6.3M (down 16% YoY from $7.5M) and EPS of -$0.06, missing the consensus estimat | May 12, 2026 |
| SLDB | PRESS-RELEASE | bearish | 6/10 | Solid Biosciences reported Q1 2026 EPS of -$0.53, a 20.9% miss versus the -$0.44 consensus, with net loss widening to $5 | May 12, 2026 |
| MAZE | PRESS-RELEASE | mixed | 5/10 | Maze Therapeutics reported Q1 2026 net loss of $24.2M ($0.45/share), missing consensus of $0.43/share by 4.7%, with lice | May 12, 2026 |
| VRCA | PRESS-RELEASE | bullish | 7/10 | Verrica Pharmaceuticals reported Q1 2026 revenue of $5.0M (beat consensus of $4.5M by 11.6%) and GAAP EPS of -$0.45 (bea | May 12, 2026 |
| OPRX | PRESS-RELEASE | mixed | 6/10 | OptimizeRx reported Q1 2026 revenue of $19.8M (down 10% YoY) and a GAAP net loss of $(0.5)M, but non-GAAP net income of | May 12, 2026 |
| NKTX | PRESS-RELEASE | neutral | 4/10 | Nkarta reported Q1 2026 EPS of -$0.37, a slight miss vs consensus of -$0.36, with no revenue. The company highlighted FD | May 12, 2026 |
| IZEA | PRESS-RELEASE | bearish | 7/10 | IZEA reported Q1 2026 revenue of $6.6M, down 18% YoY, and net loss widened to $0.8M from $0.1M. The company attributes t | May 12, 2026 |
| IKT | PRESS-RELEASE | mixed | 6/10 | Inhibikase reported a Q1 2026 net loss of $0.10 per share, slightly missing the $0.09 consensus, but operating expenses | May 12, 2026 |
| SJI | PRESS-RELEASE | neutral | 3/10 | South Jersey Industries has commenced a cash tender offer to purchase any and all of its $287.5 million outstanding 2018 | May 12, 2026 |
| IDT | PRESS-RELEASE | neutral | 2/10 | IDT's BOSS Money digital remittance app reported record Mother's Day volumes with principal up 49% YoY and remittances u | May 12, 2026 |
| SKYE | PRESS-RELEASE | bearish | 7/10 | Skye Bioscience reported Q1 2026 EPS of -$0.32, missing consensus of -$0.29 by 10.3%, with a net loss of $12.5M vs $11.1 | May 12, 2026 |
| SJI | PRESS-RELEASE | neutral | 4/10 | South Jersey Industries commenced a cash tender offer to repurchase any and all of its $287.5 million outstanding 2018 S | May 12, 2026 |
| LHAI | PRESS-RELEASE | mixed | 6/10 | Linkhome Holdings Inc. (LHAI) announced a definitive agreement to acquire 100% of Mortgage One Group, a mortgage lender | May 12, 2026 |
| NXGL | PRESS-RELEASE | neutral | 1/10 | NEXGEL, INC. announced it will report its Q1 2026 results on May 15. | May 12, 2026 |
| WFCF | PRESS-RELEASE | neutral | 1/10 | Where Food Comes From announced it will host a conference call on May 14, 2026 to discuss its Q1 2026 results. | May 12, 2026 |
| LMND | PRESS-RELEASE | neutral | 2/10 | Lemonade expands renters insurance to Louisiana, offering policies starting at $5/month via its digital platform. No fin | May 12, 2026 |
| KURA | PRESS-RELEASE | bullish | 7/10 | Kura Oncology announced that updated Phase 1 KOMET-007 data for ziftomenib in frontline AML will be presented at EHA 202 | May 12, 2026 |
| EVAX | PRESS-RELEASE | neutral | 4/10 | Evaxion announced a poster presentation at the EHA 2026 Congress detailing preclinical data for EVX-04, an off-the-shelf | May 12, 2026 |
| ALP | PRESS-RELEASE | bullish | 7/10 | Alpha Compute announced a $32.2 million, two-year lease agreement with a leading frontier AI lab for 504 NVIDIA B200 GPU | May 12, 2026 |